LISATA THERAPEUTICS, INC. Operating Expenses
LISATA THERAPEUTICS, INC. (LSTA) reported Operating Expenses of $3.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- LISATA THERAPEUTICS, INC. operating expenses for the quarter ending 2026-06-30 was $3.99M, a 19.16% decline year-over-year.
- LISATA THERAPEUTICS, INC. operating expenses for the quarter ending 2026-03-31 was $4.94M, a 15.48% decline year-over-year.
- LISATA THERAPEUTICS, INC. operating expenses for the quarter ending 2025-12-31 was $3.18M, a 46.56% decline year-over-year.
- LISATA THERAPEUTICS, INC. operating expenses for the quarter ending 2025-09-30 was $4.41M, a 17.28% decline year-over-year.
- LISATA THERAPEUTICS, INC. operating expenses for fiscal 2025 was $18.38M, a 21.49% decline from fiscal 2024.
- LISATA THERAPEUTICS, INC. operating expenses for fiscal 2024 was $23.41M, a 8.94% decline from fiscal 2023.
- LISATA THERAPEUTICS, INC. operating expenses for fiscal 2023 was $25.71M, a 55.37% decline from fiscal 2022.
- LISATA THERAPEUTICS, INC. operating expenses for fiscal 2022 was $57.60M, a 98.28% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.99M 10-Q · filed 2026-08-06 | $8.93M 10-Q · filed 2026-08-06 | $12.11M derived: sum of 3 quarters · filed 2026-08-06 | $16.53M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $4.94M 10-Q · filed 2026-05-11 | $8.12M derived: sum of 2 quarters · filed 2026-05-11 | $12.54M derived: sum of 3 quarters · filed 2026-05-11 | $17.47M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $7.59M derived: sum of 2 quarters · filed 2026-03-12 | $12.53M derived: sum of 3 quarters · filed 2026-08-06 | $18.38M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $4.41M 10-Q · filed 2025-11-06 | $9.35M derived: sum of 2 quarters · filed 2026-08-06 | $15.20M 10-Q · filed 2025-11-06 | $21.15M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $4.94M 10-Q · filed 2026-08-06 | $10.79M 10-Q · filed 2026-08-06 | $16.73M derived: sum of 3 quarters · filed 2026-08-06 | $22.07M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $5.85M 10-Q · filed 2026-05-11 | $11.80M derived: sum of 2 quarters · filed 2026-05-11 | $17.13M derived: sum of 3 quarters · filed 2026-05-11 | $22.66M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $11.29M derived: sum of 2 quarters · filed 2026-03-12 | $16.81M derived: sum of 3 quarters · filed 2026-03-12 | $23.41M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $5.34M 10-Q · filed 2025-11-06 | $10.86M derived: sum of 2 quarters · filed 2025-11-06 | $17.46M 10-Q · filed 2025-11-06 | $23.48M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $5.52M 10-Q · filed 2025-08-07 | $12.12M 10-Q · filed 2025-08-07 | $18.15M derived: sum of 3 quarters · filed 2025-08-07 | $24.11M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $6.60M 10-Q · filed 2025-05-08 | $12.63M derived: sum of 2 quarters · filed 2025-05-08 | $18.59M derived: sum of 3 quarters · filed 2025-05-08 | $25.46M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.99M derived: sum of 2 quarters · filed 2025-02-27 | $18.86M derived: sum of 3 quarters · filed 2025-02-27 | $25.71M 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $5.96M 10-Q · filed 2024-11-12 | $12.84M derived: sum of 2 quarters · filed 2024-11-12 | $19.68M 10-Q · filed 2024-11-12 | $26.22M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $6.88M 10-Q · filed 2024-08-12 | $13.72M 10-Q · filed 2024-08-12 | $20.26M derived: sum of 3 quarters · filed 2024-08-12 | $57.98M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $6.84M 10-Q · filed 2024-05-09 | $13.38M derived: sum of 2 quarters · filed 2024-05-09 | $51.10M derived: sum of 3 quarters · filed 2024-05-09 | $57.82M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $44.26M derived: sum of 2 quarters · filed 2024-02-29 | $50.98M derived: sum of 3 quarters · filed 2024-02-29 | $57.60M 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | $37.72M 10-Q · filed 2023-11-02 | $44.44M derived: sum of 2 quarters · filed 2023-11-02 | $51.06M 10-Q · filed 2023-11-02 | $57.91M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $6.72M 10-Q · filed 2023-08-14 | $13.34M 10-Q · filed 2023-08-14 | $20.19M derived: sum of 3 quarters · filed 2023-08-14 | $27.16M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $6.62M 10-Q · filed 2023-05-09 | $13.47M derived: sum of 2 quarters · filed 2023-05-09 | $20.44M derived: sum of 3 quarters · filed 2023-05-09 | $27.58M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $13.82M derived: sum of 2 quarters · filed 2023-03-30 | $20.96M derived: sum of 3 quarters · filed 2023-03-30 | $29.05M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $6.97M 10-Q · filed 2022-11-10 | $14.12M derived: sum of 2 quarters · filed 2022-11-10 | $22.20M 10-Q · filed 2022-11-10 | $27.65M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $7.15M 10-Q · filed 2022-08-04 | $15.23M 10-Q · filed 2022-08-04 | $20.68M derived: sum of 3 quarters · filed 2022-08-04 | $26.03M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $8.09M 10-Q · filed 2022-05-05 | $13.53M derived: sum of 2 quarters · filed 2022-05-05 | $18.88M derived: sum of 3 quarters · filed 2022-05-05 | $23.17M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $10.80M derived: sum of 2 quarters · filed 2022-03-22 | $15.09M derived: sum of 3 quarters · filed 2022-03-22 | $19.14M 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $5.35M 10-Q · filed 2021-11-04 | $9.64M derived: sum of 2 quarters · filed 2021-11-04 | $13.70M 10-Q · filed 2021-11-04 | $18.78M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $4.29M 10-Q · filed 2021-08-05 | $8.35M 10-Q · filed 2021-08-05 | $13.43M derived: sum of 3 quarters · filed 2021-08-05 | $18.50M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $4.06M 10-Q · filed 2021-05-06 | $9.14M derived: sum of 2 quarters · filed 2021-05-06 | $14.21M derived: sum of 3 quarters · filed 2021-05-06 | $19.56M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $10.15M derived: sum of 2 quarters · filed 2021-02-25 | $15.50M derived: sum of 3 quarters · filed 2021-02-25 | $20.09M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | $5.07M 10-Q · filed 2020-11-05 | $10.42M derived: sum of 2 quarters · filed 2020-11-05 | $15.01M 10-Q · filed 2020-11-05 | $18.81M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $5.35M 10-Q · filed 2020-08-13 | $9.94M 10-Q · filed 2020-08-13 | $13.73M derived: sum of 3 quarters · filed 2020-08-13 | $17.50M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $4.59M 10-Q · filed 2020-05-07 | $8.39M derived: sum of 2 quarters · filed 2020-05-07 | $12.15M derived: sum of 3 quarters · filed 2020-05-07 | $16.42M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $7.56M derived: sum of 2 quarters · filed 2020-03-05 | $11.83M derived: sum of 3 quarters · filed 2020-03-05 | $16.99M 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | $3.76M 10-Q · filed 2019-11-06 | $3.76M 10-Q · filed 2018-11-08 | $8.03M derived: sum of 2 quarters · filed 2019-11-06 | $13.19M 10-Q · filed 2019-11-06 | $13.19M 10-Q · filed 2018-11-08 | $20.51M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2018-06-30 | $4.27M 10-Q · filed 2019-08-08 | $4.27M 10-Q · filed 2018-08-09 | $9.43M 10-Q · filed 2019-08-08 | $9.43M 10-Q · filed 2018-08-09 | $16.75M derived: sum of 3 quarters · filed 2019-08-08 | $22.88M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | $5.16M 10-Q · filed 2019-05-09 | $5.16M 10-Q · filed 2018-05-10 | $12.48M derived: sum of 2 quarters · filed 2019-05-09 | $18.61M derived: sum of 3 quarters · filed 2019-05-09 | $26.32M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $7.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $13.45M derived: sum of 2 quarters · filed 2019-03-14 | $21.16M derived: sum of 3 quarters · filed 2019-03-14 | $27.59M 10-K · filed 2019-03-14 | $27.59M 10-K · filed 2018-03-22 | |||
| 2017-09-30 | $6.13M 10-Q · filed 2018-11-08 | $13.84M derived: sum of 2 quarters · filed 2018-11-08 | $20.27M 10-Q · filed 2018-11-08 | $25.77M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $7.71M 10-Q · filed 2018-08-09 | $14.14M 10-Q · filed 2018-08-09 | $19.64M derived: sum of 3 quarters · filed 2018-08-09 | $25.36M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $6.43M 10-Q · filed 2018-05-10 | $17.45M 10-Q · filed 2017-05-15 | $11.92M derived: sum of 2 quarters · filed 2018-05-10 | $17.65M derived: sum of 3 quarters · filed 2018-05-10 | $25.06M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $11.22M derived: sum of 2 quarters · filed 2018-03-22 | $18.63M derived: sum of 3 quarters · filed 2018-03-22 | $29.50M 10-K · filed 2018-03-22 | $66.62M 10-K · filed 2017-03-17 | |||
| 2016-09-30 | $5.73M 10-Q · filed 2017-11-09 | $16.18M 10-Q · filed 2016-11-07 | $13.13M derived: sum of 2 quarters · filed 2017-11-09 | $24.01M 10-Q · filed 2017-11-09 | $50.53M 10-Q · filed 2016-11-07 | $98.97M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $7.41M 10-Q · filed 2017-08-10 | $15.79M 10-Q · filed 2016-08-09 | $18.28M 10-Q · filed 2017-08-10 | $34.35M 10-Q · filed 2016-08-09 | $93.24M derived: sum of 3 quarters · filed 2017-08-10 | $109.51M derived: sum of 4 quarters · filed 2017-08-10 | ||
| 2016-03-31 | $18.56M 10-Q · filed 2017-05-15 | $85.83M derived: sum of 2 quarters · filed 2017-05-15 | $102.10M derived: sum of 3 quarters · filed 2017-05-15 | $133.64M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $67.27M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $83.54M derived: sum of 2 quarters · filed 2017-03-17 | $115.08M derived: sum of 3 quarters · filed 2017-03-17 | $136.34M 10-K · filed 2017-03-17 | ||||
| 2015-09-30 | $16.27M 10-Q · filed 2016-11-07 | $47.81M derived: sum of 2 quarters · filed 2016-11-07 | $69.07M 10-Q · filed 2016-11-07 | $89.90M derived: sum of 4 quarters · filed 2016-11-07 | ||||
| 2015-06-30 | $31.54M 10-Q · filed 2016-08-09 | $52.80M 10-Q · filed 2016-08-09 | $73.63M derived: sum of 3 quarters · filed 2016-08-09 | $94.00M derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | $21.26M 10-Q · filed 2016-05-05 | $42.09M derived: sum of 2 quarters · filed 2016-05-05 | $62.47M derived: sum of 3 quarters · filed 2016-05-05 | $79.39M derived: sum of 4 quarters · filed 2016-05-05 | ||||
| 2014-12-31 | $20.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $41.21M derived: sum of 2 quarters · filed 2016-03-15 | $58.13M derived: sum of 3 quarters · filed 2016-03-15 | $75.68M 10-K · filed 2016-03-15 | ||||
| 2014-09-30 | $20.38M 10-Q · filed 2015-11-05 | $37.30M derived: sum of 2 quarters · filed 2015-11-05 | $54.85M 10-Q · filed 2015-11-05 | $69.42M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $16.92M 10-Q · filed 2015-08-06 | $34.47M 10-Q · filed 2015-08-06 | $49.05M derived: sum of 3 quarters · filed 2016-03-15 | $62.07M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $17.55M 10-Q · filed 2015-05-06 | $32.13M derived: sum of 2 quarters · filed 2016-03-15 | $45.15M derived: sum of 3 quarters · filed 2016-03-15 | $57.68M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $14.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $27.59M derived: sum of 2 quarters · filed 2016-03-15 | $40.12M derived: sum of 3 quarters · filed 2016-03-15 | $51.48M 10-K · filed 2016-03-15 | $38.53M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $13.02M 10-Q · filed 2014-10-30 | $10.04M 10-Q · filed 2013-11-07 | $25.55M derived: sum of 2 quarters · filed 2014-10-30 | $36.90M 10-Q · filed 2014-10-30 | $27.30M 10-Q · filed 2013-11-07 | $57.04M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $12.53M 10-Q · filed 2014-08-07 | $8.29M 10-Q · filed 2013-08-08 | $23.88M 10-Q · filed 2014-08-07 | $17.26M 10-Q · filed 2013-08-08 | $44.02M derived: sum of 3 quarters · filed 2015-03-02 | $52.79M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | $11.36M 10-Q · filed 2014-05-08 | $8.96M 10-Q · filed 2013-05-09 | $31.49M derived: sum of 2 quarters · filed 2015-03-02 | $40.26M derived: sum of 3 quarters · filed 2015-03-02 | $47.71M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | $20.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $28.91M derived: sum of 2 quarters · filed 2015-03-02 | $36.36M derived: sum of 3 quarters · filed 2015-03-02 | $44.72M 10-K · filed 2015-03-02 | $32.77M 10-K · filed 2013-03-11 | |||
| 2012-09-30 | $8.78M 10-Q · filed 2013-11-07 | $16.22M derived: sum of 2 quarters · filed 2013-11-07 | $24.58M 10-Q · filed 2013-11-07 | $33.04M derived: sum of 4 quarters · filed 2013-11-07 | ||||
| 2012-06-30 | $7.45M 10-Q · filed 2013-08-08 | $15.81M 10-Q · filed 2013-08-08 | $24.26M derived: sum of 3 quarters · filed 2013-08-08 | $31.78M derived: sum of 4 quarters · filed 2013-08-08 | ||||
| 2012-03-31 | $8.36M 10-Q · filed 2013-05-09 | $12.17M 10-Q · filed 2012-05-11 | $16.82M derived: sum of 2 quarters · filed 2013-05-09 | $24.33M derived: sum of 3 quarters · filed 2013-05-09 | $34.79M derived: sum of 4 quarters · filed 2013-05-09 | |||
| 2011-12-31 | $8.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $15.97M derived: sum of 2 quarters · filed 2013-03-11 | $26.43M derived: sum of 3 quarters · filed 2013-03-11 | $35.41M 10-K · filed 2013-03-11 | $72.28M 10-K · filed 2012-03-20 | |||
| 2011-09-30 | $7.52M 10-Q · filed 2012-11-13 | $11.30M 10-Q · filed 2011-11-10 | $17.98M derived: sum of 2 quarters · filed 2012-11-13 | $26.95M 10-Q · filed 2012-11-13 | $39.60M 10-Q · filed 2011-11-10 | $27.85M derived: sum of 4 quarters · filed 2012-11-13 | ||
| 2011-06-30 | $10.46M 10-Q · filed 2012-08-14 | $19.43M 10-Q · filed 2012-08-14 | $20.33M derived: sum of 3 quarters · filed 2012-08-15 | $31.32M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2011-03-31 | $12.39M 10-Q · filed 2012-05-11 | $9.87M derived: sum of 2 quarters · filed 2012-08-15 | $20.86M derived: sum of 3 quarters · filed 2012-08-15 | |||||
| 2010-12-31 | -$2.52M derived: 8-K 12 month − 10-Q 9 month · filed 2012-08-15 | $8.47M derived: sum of 2 quarters · filed 2012-08-15 | $26.03M 8-K · filed 2012-08-15 | $39.03M 10-K · filed 2012-03-20 | ||||
| 2010-09-30 | $10.99M 10-Q · filed 2011-11-10 | $28.56M 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |